Preview

Проблемы Эндокринологии

Расширенный поиск

Распространенность и возможные механизмы развития новообразований при акромегалии

https://doi.org/10.14341/probl201359542-46

Полный текст:

Аннотация

Представлены данные о распространенности при акромегалии злокачественных опухолей щитовидной железы, желудочно-кишечного тракта, молочной железы, предстательной железы и яичек. Обсуждаются возможные механизмы развития новообразований, а также иммуногистохимические особенности опухолей у пациентов с акромегалией.

Список литературы

1. Colao A., Ferone D., Marzullo P., Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocrinol Rev 2004; 25: 1: 102-152.

2. Baldvinsdottir T., Jonasson J.G., Thorsson A.V. Epidemiology of pituitary tumorous in Iceland 1955-2007: a Nationwide study. 10th European Congress of Endocrinology, 3-7 May, Berlin, Germany. Endocrine Abstracts 2008; 16: 315.

3. Bates A.S., Vant Hoff W., Jones J.M. Does treatment of acromegaly affect life expectancy? Metabolism 1995; 44: Suppl 1: 1-5.

4. Ayuk J., Clayton R.N., Holder G., Sheppard M.C., Stewart P.M., Bates A.S. Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. J Clin Endocrinol Metabol 2004; 89: 4: 1613-1617.

5. Melmed S.M. J Clin Endocrinol Metabol 2001; 86: 2929-2934; Mestrón A., Webb S.M. In: Endocrine Society. San Francisco 2002; abstract.

6. Brunner J.E., Johnson C.C., Zafar S., Peterson E.L., Mellinger R.C. Colon cancer and polyps in acromegaly: increased risk associated with family history of colon cancer. Clin Endocrinol (Oxf) 1990; 32: 1: 65-71.

7. Orme S.M., McNally R.J., Cartwright R.A., Belchetz P.E. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metabol 1998; 83: 8: 2730-2734.

8. Ron E., Gridley Z., Hrubec Z., Page W., Arora S., Fraumeni J.F. Acromegaly and gastrointestinal cancer. Cancer 1991; 68: 1673-1677.

9. Jenkins P.J., Besser M. Acromegaly and cancer: a problem. J Clin Endocrinol Metabol 2001; 86: 2935-2941.

10. Colao A., Pivonello R., Galdiero M., Auriemma R.S., Ferone D., Marzullo P., Lombardi G. Fasting insulin levels are predictors of colonic lesions in patients with acromegaly: an observational, open, prospective study in 189 patients. In: 9th European Congress of Endocrinology, 2007, 28 April - 2 May, Budapest (Hungary). Endocrine 2007; 14: OC3.7: Abstracts.

11. Gullu B.E., Celik O., Gazioglu N., Kadioglu P. Thyroid cancer is the most common cancer associated with acromegaly. Pituitary 2010; 13: 3: 242-248.

12. Bałdys-Waligórska A., Krzentowska A., Gołkowski F., Sokołowski G., Hubalewska-Dydejczyk A. The prevalence of benign and malignant neoplasms in acromegalic patients. Pol J Endocrinol 2010; 61: 1: 29-34.

13. Tita P., Ambrosio M.R., Scollo C., Carta A., Gangemi P., Bondanelli M., Vigneri R., degli Uberti E.C., Pezzino V. High prevalence of differentiated thyroid carcinoma in acromegaly. Clin Endocrinol (Oxf) 2005; 63: 2: 161-167.

14. Maira Cristina Carvalho dos Santos, Gilvan Cortes Nascimento, Ana Giselia Cortes Nascimento, Tiviane Carvalho, Maria Honorina Lopes, PriscillaAmorim, Alice Alves, Conceicao Parente, Renan Montenegro, Monica Alban, Lucio Vilar, Manuel dos Santos Faria. Prevalence of Thyroid Cancer in Patients with Acromegaly: a Case-Control Study. Lieqe 2010. Eur NeuroEndocrin Ass Congress 2010.

15. Corrêa L.L., Lima G.A., Paiva H.B., Silva C.M., Cavallieri S.A., Miranda L.C., Gadelha M.R. Arq Bras Prostate cancer and acromegaly. Endocrinol Metabol 2009; 53: 8: 963-968.

16. Роживанов Р.В., Фабричнова А.А., Лепетухин А.Е., Дубский С.А., Курбатов Д.Г. Pиcк развития гиперплазии и рака предстательной железы при акромегалии. Пробл эндокринол 2010; 5: 30-32.

17. Webb S.M., Casanueva F., Wass J.A. . Oncological complications of excess GH in acromegaly. Department of Endocrinology, Hospital Sant Pau, Autonomous University of Barcelona (Spain). Pituitary 2002; 5: 1: 21-25.

18. Zavos C., Andreadis C., Diamantopoulos N., Mouratidou D. A hypothesis on the role of insulin-like growth factor I in testicular germ cell tumours. Med Hypotheses 2004; 63: 3: 511-514.

19. Clayton P.E., Banerjee I., Murray P.G., Renehan A.G. Growth hormone, the insulin-like growth factor axis, insulin and cancer risk. Nat Rev Endocrinol 2011; 7: 1: 11-24.

20. Orme S.M. J Clin Endocrinol Metab 1998; 83: 2730-2734; Nabarro J.D. Clin Endocrinol 1987; 26: 481-512.

21. Dworakowska D., Gueorguiev M., Kelly P., Monson J.P., Besser G.M., Chew S.L., Akker S.A., Drake W.M., Fairclough P.D., Grossman A.B., Jenkins P.J. Repeated colonoscopic screening of patients with acromegaly: 15-year experience identifies those at risk of new colonic neoplasia and allows for effective screening guidelines. Eur J Endocrinol 2010; 163: 1: 21-28.

22. Renehan A.G., Bhaskar P., Painter J.E., O' Dwyer S.T., Haboubi N., Ball S.G., Shalet S.M. The prevalence and characteristics of colorectal neoplasia in acromegaly. Clin Endocrinol Metabol 2000; 85: 3417-3424.

23. Resmini E., Tagliafico A., Bacigalupo L., Giordano G., Melani E., Rebora A., Minuto F., Rollandi G.A., Ferone D. CT-colonography in acromegaly. 90th Annual Meeting. San Francisco 2008; 2-728.

24. Ma J., Giovannucci E., Pollak M., June M., Chan J., Gaziano M., Willett W., Stampfer M.J. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-1 and IGF-binding protein-3. J Nat Cancer Inst 1999; 91: 620-625.

25. McCarthy K., Laban C., McVittie C.J., Ogunkolade W., Khalaf S., Bustin S., Carpenter R., Jenkins P.J. Source. The expression and function of IGFBP-3 in normal and malignant breast tissue. Anticancer Res 2009; 29: 10: 3785-3790.

26. Пронин А.В. Состояние органов репродуктивной системы у пациенток с акромегалией: Автореф. дис. ... канд. мед. наук. М 2010.

27. Ogunkolade B.W., Boucher B.J., Fairclough P.D., Hitman G.A., Dorudi S., Jenkins P.J., Bustin S.A. Source Expression of 25-hydroxyvitamin D-1-alpha-hydroxylase mRNA in individuals with colorectal cancer. Lancet 2002; 359: 9320: 1831-1832.

28. Bayerdörffer E., Mannes G.A., Ochsenkühn T., Dirschedl P., Wiebecke B., Paumgartner G. Unconjugated secondary bile acids in the serum of patients with colorectal adenomas. Gut 1995; 36: 2: 268-273.

29. Dutta P., Bhansali A., Vaiphei K., Dutta U., Ravi Kumar P., Masoodi S., Mukherjee K.K., Varma A., Kochhar R. Colonic neoplasia in acromegaly: increased proliferation or deceased apoptosis? Pituitary. Postgraduate Institute of Medical Education and Research, Chandigarh, Departments of Endocinology 2012; 15:2:166-173: 160012: Abstracts.

30. Sekizawa N., Hayakawa E., Tsuchiya K., Yoshimoto T., Akashi T., Fujii T., Yamada S., Hirata Y. Source. Acromegaly associated with multiple tumors. Intern Med 2009; 48: 15: 1273-1278.


Для цитирования:


., . Распространенность и возможные механизмы развития новообразований при акромегалии. Проблемы Эндокринологии. 2013;59(5):42-46. https://doi.org/10.14341/probl201359542-46

For citation:


Oleĭnik O.V., Molitvoslovova N.N. The prevalence and possible mechanisms of the development of neoplasms in the patients with acromegalia. Problems of Endocrinology. 2013;59(5):42-46. (In Russ.) https://doi.org/10.14341/probl201359542-46

Просмотров: 51


ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)